Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adolfo Domenech

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Archivos De Bronconeumologia|July 6, 2014
Nebulized therapy. SEPAR yearCasilda Olveira, Ana Muñoz, Adolfo Domenech
Enfermeria Clinica (English Edition)|December 31, 2017
Effectiveness of a respiratory rehabilitation programme in patients with chronic obstructive pulmonary diseaseMaría Jesús Prunera-Pardell, Susana Padín-López, Adolfo Domenech-Del Rio, et al.
Lung|July 12, 2013
Clinical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary diseaseMarc Miravitlles, Cayo García-Polo, Adolfo Domenech, et al.
Respiratory Medicine|July 29, 2018
High risk of subclinical atherosclerosis in COPD exacerbator phenotypeAdolfo Domenech, Ana Muñoz-Montiel, Natalia García-Casares, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|February 10, 2018
Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE studyCarlos A Jiménez-Ruiz, Marcos Garcia Rueda, Manuel A Martinez Muñiz, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Archivos De Bronconeumologia|July 6, 2014
Nebulized therapy. SEPAR yearCasilda Olveira, Ana Muñoz, Adolfo Domenech
Enfermeria Clinica (English Edition)|December 31, 2017
Effectiveness of a respiratory rehabilitation programme in patients with chronic obstructive pulmonary diseaseMaría Jesús Prunera-Pardell, Susana Padín-López, Adolfo Domenech-Del Rio, et al.
Lung|July 12, 2013
Clinical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary diseaseMarc Miravitlles, Cayo García-Polo, Adolfo Domenech, et al.
Respiratory Medicine|July 29, 2018
High risk of subclinical atherosclerosis in COPD exacerbator phenotypeAdolfo Domenech, Ana Muñoz-Montiel, Natalia García-Casares, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|February 10, 2018
Varenicline in smokers with severe or very severe COPD after 24 weeks of treatment. A descriptive analysis: VALUE studyCarlos A Jiménez-Ruiz, Marcos Garcia Rueda, Manuel A Martinez Muñiz, et al.
Pageof 1